Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect.

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

the hospital, the patient had been suffering from prolonged difficulty in urination along with repeated episodes of urinary retention, which had considerably impacted his quality of life ...

TEM is integrating externally developed AI pathology into its ecosystem to improve risk prediction and personalize prostate ...

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

UVA Health Prince William Medical Center has begun offering Aquablation therapy, an advanced AI-powered treatment for benign ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...